Arcellx, Inc.
NASDAQ: ACLX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Rami Elghandour
- Employees
- 163
- Headquarters
- Redwood City, United States
- IPO year
- 2022
- Market cap
- $6.7B
- Website
- https://arcellx.com
Loading ACLX…
Loading profile data…Frequently asked questions about ACLX
What does Arcellx, Inc. (ACLX) do?
Arcellx, Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering immunotherapeutic solutions for patients battling cancer and other intractable diseases. A cornerstone of their pipeline is CART-ddBCMA, an advanced ddCAR product candidate currently undergoing a Phase 1 clinical trial. This investigational treatment targets indiv...
Where does ACLX trade?
Arcellx, Inc. (ACLX) trades on the NASDAQ Global Select.
What sector is ACLX in?
Arcellx, Inc. (ACLX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Arcellx, Inc.?
Rami Elghandour is the chief executive officer of Arcellx, Inc. (ACLX).
Where is Arcellx, Inc. headquartered?
Arcellx, Inc. is headquartered in United States.
Does ACLX pay a dividend?
Arcellx, Inc. (ACLX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACLX go public?
Arcellx, Inc. (ACLX) completed its initial public offering in 2022.